Ameriprise Financial Inc Immuno Gen, Inc. Transaction History

Ameriprise Financial Inc

$381 Billion
Q3 2024

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 14, 2024	BUY	$12.46 - $29.95 $94,932 - $228,189	7,619 New	7,619 $225,000
Q2 2023 Aug 14, 2023	SELL	$3.75 - $20.05 $918,945 - $4.91 Million	-245,052 Reduced 85.42%	41,815 $789,000
Q1 2023 May 15, 2023	SELL	$3.67 - $4.92 $3,236 - $4,339	-882 Reduced 0.31%	286,867 $1.1 Million
Q4 2022 Feb 14, 2023	BUY	$4.55 - $6.31 $741,577 - $1.03 Million	162,984 Added 130.63%	287,749 $1.43 Million
Q3 2022 Nov 14, 2022	SELL	$4.48 - $6.47 $6,500 - $9,387	-1,451 Reduced 1.15%	124,765 $596,000
Q2 2022 Aug 15, 2022	BUY	$3.15 - $5.76 $2,129 - $3,893	676 Added 0.54%	126,216 $568,000
Q1 2022 May 16, 2022	BUY	$4.26 - $7.48 $534,800 - $939,039	125,540 New	125,540 $598,000
Q2 2021 Aug 16, 2021	SELL	$5.79 - $8.6 $32.4 Million - $48.1 Million	-5,595,683 Closed	0 $0
Q1 2021 May 17, 2021	BUY	$6.5 - $10.53 $24.3 Million - $39.4 Million	3,738,190 Added 201.25%	5,595,683 $45.3 Million
Q4 2020 Feb 12, 2021	BUY	$3.7 - $7.66 $1.63 Million - $3.37 Million	439,857 Added 31.03%	1,857,493 $12 Million
Q3 2020 Nov 16, 2020	SELL	$3.45 - $4.89 $67,319 - $95,418	-19,513 Reduced 1.36%	1,417,636 $5.1 Million
Q2 2020 Aug 14, 2020	BUY	$3.32 - $5.34 $4.69 Million - $7.54 Million	1,412,568 Added 5746.58%	1,437,149 $6.61 Million
Q1 2020 May 15, 2020	BUY	$2.12 - $6.8 $3,432 - $11,009	1,619 Added 7.05%	24,581 $84,000
Q4 2019 Feb 14, 2020	BUY	$2.25 - $5.8 $4,981 - $12,841	2,214 Added 10.67%	22,962 $117,000
Q3 2019 Nov 14, 2019	BUY	$2.22 - $3.39 $46,060 - $70,335	20,748 New	20,748 $50,000
Q3 2018 Nov 14, 2018	SELL	$8.6 - $11.26 $1.1 Million - $1.44 Million	-127,776 Closed	0 $0
Q2 2018 Aug 14, 2018	BUY	$9.52 - $12.15 $208,221 - $265,744	21,872 Added 20.65%	127,776 $1.24 Million
Q1 2018 May 15, 2018	BUY	$6.7 - $12.95 $709,556 - $1.37 Million	105,904 New	105,904 $1.11 Million
Q4 2017 Feb 12, 2018	SELL	$5.07 - $7.92 $1.06 Million - $1.65 Million	-208,574 Closed	0 $0
Q3 2017 Nov 07, 2017	BUY	$5.4 - $8.47 $1.13 Million - $1.77 Million	208,574	208,574 $1.6 Million

Others Institutions Holding IMGN

# of Institutions

Shares Held

1.41M

Call Options Held

Put Options Held

View Full List

About ImmunoGen, Inc.

Ticker IMGN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 220,712,992
Description
ImmunoGen, Inc., a clinical-stage biotechnology company, develops antibody-drug conjugate (ADC) therapies to treat cancer. The company's product candidates include mirvetuximab soravtansine, an ADC targeting folate-receptor alpha (FRa), which is in Phase III clinical trial for the treatment of platinum-resistant ovarian cancer; and Pivekimab sun...

More about IMGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Ameriprise Financial Inc, based on Form 13F filings with the SEC.

News

Stay updated on Ameriprise Financial Inc with notifications on news.

Account